Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/2014
05/22/2014US20140141006 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
05/22/2014US20140141005 Agents and method for treating inflammation-related conditions and diseases
05/22/2014US20140141003 Neutralizing prolactin receptor antibody mat3 and its therapeutic use
05/22/2014US20140141000 Bispecific EGFR/C-Met Antibodies
05/22/2014US20140140995 Compositions and methods of treating disease with fgfr fusion proteins
05/22/2014US20140140989 Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof
05/22/2014US20140140982 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
05/22/2014US20140140979 Compositions And Methods Of Use of Phorbol Esters For Treatment of Stroke
05/22/2014US20140140977 Methods and Kits for Assessing Heparanase Procoagulant Activity, Compositions Comprising Heparanase, and Methods for the Treatment of Coagulation Related Disorders
05/22/2014US20140140971 Compositions comprising alkaline sphingomyelinases for use as a dietetic preparation, food supplement or pharmaceutical product and methods for using them
05/22/2014US20140140958 Spiro[2.4]heptanes for Treatment of Flaviviridae Infections
05/22/2014US20140140957 Spiro[2.4]heptanes for Treatment of Flaviviridae Infections
05/22/2014US20140140956 Biaryl derivatives as bromodomain inhibitors
05/22/2014US20140140955 Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
05/22/2014US20140140953 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
05/22/2014US20140140952 D-Alanine Ester of Sp-Nucleoside Analog
05/22/2014US20140140951 D-Alanine Ester of Rp-Nucleoside Analog
05/22/2014US20140140924 Humanized L243 Antibodies
05/21/2014EP2732817A1 A compound for use in treating injury associated with exposure to phosgene or chlorine gas
05/21/2014EP2731596A2 Combined therapeutic agent
05/21/2014CN103813789A 含有高纯度epa的抗肥胖药 Anti-obesity drugs containing high purity epa's
05/21/2014CN103804684A 一种新型聚原酸酯药用辅料及其缓释药物新制剂 A new polyorthoesters new pharmaceutical excipients and release pharmaceutical preparations
05/21/2014CN103800919A Tuft1在制备肝癌诊断和治疗制剂中的应用 Tuft1 in the preparation of HCC diagnosis and treatment formulations
05/21/2014CN103800906A 用于刺激哺乳动物对病原体的先天免疫抵抗力的组合物 Compositions for stimulating the mammalian innate immune resistance to pathogens of
05/21/2014CN103800905A 联合应用c-MET抑制剂与丁酸钠治疗癌症的方法 C-MET inhibitor sodium butyrate method of treating cancer in combination
05/21/2014CN103800904A Hat乙酰化启动子和其组合物在促进免疫原性中的用途 Hat acetylation promoters and combinations thereof in promoting the use of the immunogenic
05/21/2014CN103800903A 用于治疗痤疮和其它病症的内脂素治疗药物 Visfatin used to treat acne and other disorders of therapeutic drugs
05/21/2014CN103800902A 含有齐墩果酸的药物组合物及其医药用途 Pharmaceutical compositions containing oleanolic acid and its medicinal uses
05/21/2014CN103800897A 一种肿瘤特异抗原表位多肽负载的树突状细胞疫苗制备方法及其试剂盒 A tumor-specific antigen epitope peptide loaded dendritic cell vaccine preparation method and kit
05/21/2014CN103800300A 减少阿片样物质缓释口服剂型的醇诱导的剂量倾卸的方法 Reducing alcohol-induced dose of opioid sustained release oral dosage form, method of dumping
05/21/2014CN102943108B 用于肺癌的诊断、预后和治疗的基于微小rna的方法和组合物 Methods and compositions for the diagnosis, prognosis and treatment of lung cancer based on the micro rna
05/21/2014CN102847160B 一种畜禽用复方喹诺酮类注射液及其制备方法 A livestock quinolone compound injection and its preparation method
05/21/2014CN102740864B 对抗外周器官缺陷或衰竭的基于氩的可吸入的气体药物 Against the outer periphery of the defect or failure of an organ based on the argon gas can be inhaled drug
05/21/2014CN102441157B 蛙皮素／胃泌素释放肽拮抗剂用于治疗急性肺损伤的用途 Uses bombesin / gastrin releasing peptide antagonist for the treatment of acute lung injury
05/21/2014CN101721354B 由双挤压法制备的眼植入物 Ocular implants prepared by double extrusion legal
05/21/2014CN101675992B β-淀粉样蛋白-类似物-T-细胞表位疫苗 β- amyloid - like -T- cell epitope vaccine
05/20/2014US8729337 Production of polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs
05/20/2014US8729126 Use of pufas for treating skin inflammation
05/20/2014US8729099 Pharmaceutically active piperidine derivatives
05/20/2014US8728797 Yeast membrane protein expression system and its application in drug screening
05/20/2014US8728747 Alteration of cell membrane for new functions
05/20/2014US8728523 Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
05/20/2014US8728511 Method of treatment comprising administering controlled release melatonin
05/20/2014US8728507 Non-systemic control of parasites
05/20/2014US8728489 Immunotherapy for chronic hepatitis C virus infection
05/20/2014US8728468 Treatments for cancer
05/20/2014CA2716893C Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease
05/20/2014CA2591399C Aminocarboxylic acid derivative and medicinal use thereof
05/20/2014CA2471504C Ligand for g-protein coupled receptor gpr43 and uses thereof
05/20/2014CA2448567C Modulators of nucleic acid ligands
05/15/2014WO2014074846A1 Methods for the treatment of bone loss
05/15/2014WO2014073659A1 Oral administration composition for ameliorating or preventing hypertension
05/15/2014WO2014073529A1 MEDICINE COMPRISING MODULATOR OF ACTIVITY OF CD300a-EXPRESSING CELL ASSOCIATED WITH ALLERGIC DISEASE, CD300a GENE KNOCK-OUT MOUSE, AND USE OF MODULATOR OF ACTIVITY OF CD300a-EXPRESSING CELL
05/15/2014WO2014073209A1 Therapeutic agent for keratoconjunctive disorders
05/15/2014WO2014072937A1 Pharmaceutical compositions containing a pde4 inhibitor and a pi3 delta or dual pi3 delta-gamma kinase inhibitor
05/15/2014WO2014072673A1 Fixed dose pharmaceutical composition comprising deferasirox and deferipone
05/15/2014WO2014072446A1 Method for inducing il-2-free proliferation of gamma delta t cells
05/15/2014US20140135487 Immunostimulatory g, u-containing oligoribonucleotides
05/15/2014US20140135485 6-11 bicyclic ketolide derivatives
05/15/2014US20140135389 Quinone based nitric oxide donating compounds
05/15/2014US20140135385 Ryanodine receptor inhibitors for treatment of t-cell mediated disorders
05/15/2014US20140135360 Aryl Derivatives And Uses Thereof
05/15/2014US20140135355 Abuse-Resistant Controlled-Release Opioid Dosage Form
05/15/2014US20140135342 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
05/15/2014US20140135336 Triazolopyridazine
05/15/2014US20140135335 Spiro bicyclic oxalamide compounds for the treatment of hepatitis c
05/15/2014US20140135331 Thiazole and thiadiazole compounds for inflammation and immune-related uses
05/15/2014US20140135330 Oxazolidin-2-one-Pyrimidine Derivatives
05/15/2014US20140135320 Heteroaryl derivatives and uses thereof
05/15/2014US20140135309 Sulfoximine substituted quinazolines for pharmaceutical compositions
05/15/2014US20140135308 Benzoxepin pi3k inhibitor compounds and methods of use
05/15/2014US20140135301 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
05/15/2014US20140135300 Acetamide Stereoisomer
05/15/2014US20140135298 Mutation mimicking compounds that bind to the kinase domain of egfr
05/15/2014US20140135282 Pharmaceutical composition for use in inhibiting recurrence, aggravation and metastasis of hepatocarcinoma
05/15/2014US20140135261 Peptide yy and peptide yy agonists for treatment of metabolic disorders
05/15/2014US20140135259 Treatment of hepatitis c virus
05/15/2014US20140134660 Inhibition of the beta3 subunit of l-type ca2+ channels
05/15/2014US20140134282 Nitrooxy alkanoic acids and derivatives thereof in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
05/15/2014US20140134276 Anti-tumor drug, medicament, composition, and use thereof
05/15/2014US20140134275 Therapeutic combinations for use in neoplasia
05/15/2014US20140134265 Tec family kinase inhibitor adjuvant therapy
05/15/2014US20140134262 Method of treating atherosclerosis in high triglyceride subjects
05/15/2014US20140134251 Pharmaceutical formulations and methods for treating respiratory tract infections
05/15/2014US20140134239 Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents
05/15/2014US20140134237 Type i interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis
05/15/2014US20140134233 SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE
05/15/2014US20140134225 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
05/15/2014US20140134210 Composition containing antibiotics and lysophosphatidylcholine for boosting immunity or treatment of bacterial infections
05/15/2014US20140134206 Inflammation and immunity treatments
05/15/2014US20140134193 Spliceostatin analogs and methods for their preparation
05/15/2014US20140134181 Treatment Method For Lung Remodeling Diseases
05/15/2014US20140134173 Composition and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
05/15/2014US20140134172 Anti-dll4/vegf dual variable domain immunoglobulin and uses thereof
05/15/2014US20140134170 Use of inhibitors of egfr-family receptors in the treatment of hormone refractory breast cancers
05/15/2014US20140134164 Treatment of multiple sclerosis
05/15/2014US20140134160 Gemcitabine prodrugs and uses thereof
05/15/2014US20140134159 Methods of treating neuroendocrine tumors using frizzled-binding agents
05/15/2014US20140134157 Antibodies to opgl
05/15/2014US20140134151 Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 1151